Revive Therapeutics Webcast – February 10, 2022

Michael Frank, Chairman & CEO and Derrick Welsh, COO give investors an update on the current phase III bucillamine trial for treatment of COVD-19 and psilocybin and CBD based pipeline of therapies in development.
Sign Up to Get Invitations to Our In-Person and Virtual Investor Meetings Here: http://www.torreyhillscapital.com/join-our-meetings

source